Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Fibrocystic Breasts Diagnostics Treatment Companies

ID: MRFR/Pharma/4987-HCR
100 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Fibrocystic breasts diagnostics and treatment companies focus on providing medical solutions for fibrocystic breast changes, a common condition characterized by noncancerous lumps and breast discomfort. These companies contribute to women's health by offering diagnostic tools, imaging technologies, and supportive care for managing fibrocystic breasts.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Fibrocystic Breasts Diagnostics Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.46%
2024 Market Size$ 6.06 Billion
2025 Market Size$ 6.53 Billion
2035 Market Size$ 12.13 Billion
Key Players
GE Healthcare
Siemens Healthineers
Philips Healthcare
Hologic
Fujifilm Holdings Corporation
Canon Medical Systems
Opportunities
  • Increased Awareness and Education
  • Regulatory Support and Guidelines
  • Advancements in Diagnostic Technologies

Top Industry Leaders in the Fibrocystic Breasts Diagnostics Treatment Market

Fibrocystic Breasts Diagnostics and Treatment Key Companies

Latest Fibrocystic Breasts Diagnostics and Treatment Companies Update

Contrast-enhanced spectral mammography (CESM) new technology is gaining traction for its ability to better visualize blood flow within breast lesions, potentially helping distinguish benign fibrocystic changes from malignant tumors. Companies like Siemens Healthineers are actively developing and introducing CESM systems.

3D tomosynthesis advanced mammogram technique provides detailed 3D images of the breast, aiding in differentiating complex structures like fibrocystic changes and reducing the risk of overlapping tissue obscuring potentially suspicious lesions.List of Fibrocystic Breasts Diagnostics and Treatment Key Companies in the Market

  • Argon Medical Devices
  • Boston Scientific
  • CareFusion Corporation (Acquired by Becton, Dickinson and Company)
  • C. R. Bard, Inc
  • Cook Medical
  • Devicor Medical Products Inc.
  • Gallini Medical Devices
  • Hologic, Inc.
  • INRAD, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Bayer AG
  • Allergan plc.
Get In-Depth Insights on Key Fibrocystic Breasts Diagnostics Treatment Companies